Quine EJ, Dagan M, William J, et al. - Given that a protective impact of increased body-mass index (BMI) has been noted in patients receiving percutaneous coronary intervention, researchers investigated if increased BMI was related to a similar association in transcatheter aortic valve implantation (TAVI). For this purpose, they analyzed prospectively gathered data from 634 patients who received TAVI at 2 centres from August 2008 to April 2019. Stratification of patients was done as follows: normal weight (BMI 18.5-24.9kg/m², n=214), overweight (25-29.9kg/m², n=234) and obese (>30kg/m², n=185). Increasing age, male gender, COPD, prior balloon valvuloplasty and higher STS-PROM were the variables that were identified to be independently related to increased mortality. Findings revealed that lower long-term mortality was experienced by overweight patients vs normal weight and obese patients receiving TAVI.